| Date | Title | Description |
| 27.05.2026 | Bulletin from the Annual General Meeting 2026 of Qlife Holding AB | Bulletin from the Annual General Meeting 2026 of Qlife Holding AB
Wed, May 27, 2026 12:01 CET Report this content
Qlife Holding AB held its Annual General Meeting on 27 May 2026. At the meeting, the following resolutions were made.
The Engl... |
| 24.04.2026 | Qlife Holding AB publishes Annual Report for 2025 | Qlife Holding AB publishes Annual Report for 2025
Fri, Apr 24, 2026 08:30 CET Report this content
Qlife Holding AB's ("Qlife") Annual Report is available on Qlife's website:
Qlife’s website: https://qlifeholding.com/en/investors/f... |
| 23.04.2026 | The ISP leaves notifications under the FDI Act without action in connection with allotment to certain investors in Qlife's rights issue | The ISP leaves notifications under the FDI Act without action in connection with allotment to certain investors in Qlife's rights issue
Thu, Apr 23, 2026 15:17 CET Report this content
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY O... |
| 01.04.2026 | Qlife announces the last day of trading in BTA | Qlife announces the last day of trading in BTA
Wed, Apr 01, 2026 18:33 CET Report this content
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERICA, AUSTRALIA, BELARUS, CANADA, HONG ... |
| 24.03.2026 | Qlife announces the outcome of the rights issue and resolves on a directed issue of shares to guarantors | Qlife announces the outcome of the rights issue and resolves on a directed issue of shares to guarantors
Tue, Mar 24, 2026 08:30 CET Report this content
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE U... |
| 17.03.2026 | The subscription period in Qlife’s rights issue ends on Thursday, 19 March 2026 | The subscription period in Qlife’s rights issue ends on Thursday, 19 March 2026
Tue, Mar 17, 2026 08:45 CET Report this content
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERICA, ... |
| 17.03.2026 | Qlife provides business update on clinical progress, partnerships and commercialization initiatives | Qlife provides business update on clinical progress, partnerships and commercialization initiatives
Tue, Mar 17, 2026 09:00 CET Report this content
Qlife Holding AB (“Qlife” or the “Company”), a pioneer in clinical-grade home diagnostics, t... |
| 13.03.2026 | Hipro to accelerate Egoo development and regulatory approval in China following strong interest | Hipro to accelerate Egoo development and regulatory approval in China following strong interest
Fri, Mar 13, 2026 08:30 CET Report this content
Qlife Holding AB (“Qlife” or the “Company”) today announces that, following the recently communi... |
| 05.03.2026 | The subscription period in Qlife’s rights issue begins today | The subscription period in Qlife’s rights issue begins today
Thu, Mar 05, 2026 08:50 CET Report this content
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERICA, AUSTRALIA, BELARUS,... |
| 04.03.2026 | Qlife publishes information document due to upcoming rights issue | Qlife publishes information document due to upcoming rights issue
Wed, Mar 04, 2026 08:40 CET Report this content
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERICA, AUSTRALIA, BEL... |
| 26.02.2026 | Bulletin from Extraordinary General Meeting 2026 of Qlife Holding AB | Bulletin from Extraordinary General Meeting 2026 of Qlife Holding AB
Thu, Feb 26, 2026 11:05 CET Report this content
Qlife Holding AB (the “Company” or “Qlife”) held an Extraordinary General Meeting on 26 February 2026, at which the followi... |
| 25.02.2026 | Qlife launches pharmacy pilot project in Nordic markets | Qlife launches pharmacy pilot project in Nordic markets
Wed, Feb 25, 2026 08:30 CET Report this content
Qlife Holding AB (“Qlife” or the “Company”), a pioneer in clinical-grade home diagnostics, today announces that the previously communica... |
| 26.01.2026 | Notice of Extraordinary General Meeting 2026 in Qlife Holding AB | Notice of Extraordinary General Meeting 2026 in Qlife Holding AB
Mon, Jan 26, 2026 10:56 CET Report this content
The shareholders of Qlife Holding AB, corporate identity number 559224-8040, are hereby invited to attend an Extraordinary Gene... |
| 26.01.2026 | Qlife submits Egoo PHE home testing system for regulatory approval | Qlife submits Egoo PHE home testing system for regulatory approval
Mon, Jan 26, 2026 08:30 CET Report this content
Qlife Holding AB (“Qlife” or the “Company”), a pioneer in clinical-grade home diagnostics, today announces that the Company h... |
| 22.01.2026 | Qlife resolves on a partially guaranteed rights issue of approx. SEK 31.4 million and proposes an over-allotment option, enters bridge loan agreements and postpones the exercise period of warrants TO7 | Qlife resolves on a partially guaranteed rights issue of approx. SEK 31.4 million and proposes an over-allotment option, enters bridge loan agreements and postpones the exercise period of warrants TO7
Thu, Jan 22, 2026 20:50 CET Report this... |
| 19.01.2026 | Qlife prepares for pharmacy testing in Nordic markets | Qlife prepares for pharmacy testing in Nordic markets
Mon, Jan 19, 2026 08:30 CET Report this content
Qlife Holding AB (“Qlife” or the “Company”), a pioneer in clinical-grade home diagnostics, is preparing a pilot project for blood testing ... |
| 15.01.2026 | Egoo Health achieves breakthrough precision in key diabetes biomarker test, paving the way for partnerships | Egoo Health achieves breakthrough precision in key diabetes biomarker test, paving the way for partnerships
Thu, Jan 15, 2026 08:30 CET Report this content
Qlife Holding AB (“Qlife” or the “Company”), a pioneer in clinical-grade home diagno... |
| 23.12.2025 | Qlife provides end-year operational update on key issues | Qlife provides end-year operational update on key issues
Tue, Dec 23, 2025 08:30 CET Report this content
Qlife Holding AB (“Qlife” or the “Company”), a pioneer in clinical-grade home diagnostics, provides a year-end operational update on ke... |
| 16.12.2025 | Qlife and Hipro sign exclusive commercial agreement covering Qlife’s sale of Hipro products in EU and US markets | Qlife and Hipro sign exclusive commercial agreement covering Qlife’s sale of Hipro products in EU and US markets
Tue, Dec 16, 2025 08:31 CET Report this content
Qlife Holding AB ("Qlife" or the "Company"), a first mover ... |
| 16.12.2025 | The Letter of Intent with Hipro Biotechnology regarding the reverse takeover has been extended until 31 December 2026 and the valuation term will re-evaluated once a structure has been established | The Letter of Intent with Hipro Biotechnology regarding the reverse takeover has been extended until 31 December 2026 and the valuation term will re-evaluated once a structure has been established
Tue, Dec 16, 2025 08:30 CET Report this con... |
| 12.12.2025 | Egoo Health powers AI-driven personalized diabetes management in China | Egoo Health powers AI-driven personalized diabetes management in China
Fri, Dec 12, 2025 08:30 CET Report this content
Qlife Holding AB ("Qlife" or the "Company") is proud to announce that its Egoo Health blood testing p... |
| 05.12.2025 | Qlife’s Birmingham PKU clinical trial published with strong results – key milestone toward CE-mark submission and market launch | Qlife’s Birmingham PKU clinical trial published with strong results – key milestone toward CE-mark submission and market launch
Fri, Dec 05, 2025 11:13 CET Report this content
Qlife Holding AB (“Qlife” or the “Company”) a first mover in cli... |
| 28.05.2025 | Bulletin from the annual general meeting 2025 of Qlife Holding AB | Bulletin from the annual general meeting 2025 of Qlife Holding AB
Wed, May 28, 2025 12:18 CET Report this content
Qlife Holding AB held its annual general meeting on 28 May 2025. At the meeting, the following resolutions were made.
The Engl... |
| 13.05.2025 | The Pulse of Progress: Qlife and fischer India Lead the Charge in Innovation and Workplace Culture | In the fast-paced world of business, two companies stand out for their commitment to innovation and employee satisfaction: Qlife Holding AB and fischer India. Each company, in its own way, is reshaping its industry. Qlife is revolutionizing... |
| 07.05.2025 | Qlife Holding AB publishes Annual Report for 2024 | Qlife Holding AB publishes Annual Report for 2024
Wed, May 07, 2025 09:01 CET Report this content
Qlife Holding AB's ("Qlife") Annual Report is available on Qlife's website:
https://qlifeholding.com/en/investors/financial-reports
... |
| 29.04.2025 | The T+1 Transition: A Race Against Time for Financial Firms | The financial world is on the brink of a significant transformation. The shift to T+1 settlement is not just a technical upgrade; it’s a revolution. This change will reduce the time it takes to settle trades from two days to just one. It’s ... |
| 25.04.2025 | Kallelse till årsstämma 2025 i Qlife Holding AB | Kallelse till årsstämma 2025 i Qlife Holding AB
Fri, Apr 25, 2025 11:26 CET Report this content
Aktieägarna i Qlife Holding AB, org.nr 559224-8040, kallas till årsstämma den 28 maj 2025 kl. 11.00 i Moll Wendén Advokatbyrås lokaler på Storto... |
| 10.04.2025 | Qlife announces strategic roadmap update | Qlife announces strategic roadmap update
Thu, Apr 10, 2025 13:00 CET Report this content
Qlife is positioned at the forefront of the fast-growing at-home diagnostics market, offering lab-grade biomarker testing with global potential. In lig... |
| 26.03.2025 | Qlife Holding: A New Dawn in Home Health Testing | In the realm of healthcare, innovation is the lifeblood that fuels progress. Qlife Holding AB, a Swedish company, is poised to revolutionize home health testing with its cutting-edge Egoo Health platform. This platform aims to empower indiv... |
| 25.03.2025 | Qlife announces that it has received approval from UK authorities to initiate a clinical trial in the UK | Qlife announces that it has received approval from UK authorities to initiate a clinical trial in the UK
Tue, Mar 25, 2025 09:00 CET Report this content
The Egoo Phe System, developed to measure phenylalanine (Phe) levels associated with th... |
| 21.03.2025 | Bulletin from the extraordinary general meeting in Qlife Holding AB on 21 March 2025 | Bulletin from the extraordinary general meeting in Qlife Holding AB on 21 March 2025
Fri, Mar 21, 2025 10:32 CET Report this content
Today, on 21 March 2025, an extraordinary general meeting was held in Qlife Holding AB. A summary of the ad... |
| 14.03.2025 | Qlife announces the last day of trading in BTA | Qlife announces the last day of trading in BTA
Fri, Mar 14, 2025 17:45 CET Report this content
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERICA, AUSTRALIA, BELARUS, CANADA, HONG ... |
| 06.03.2025 | Qlife's Strategic Expansion: A Bold Move in the Biotech Arena | In the ever-evolving landscape of biotechnology, Qlife is making waves. The Swedish company, based in Göteborg, is on a mission to revolutionize home diagnostics. With its innovative platform, Egoo.Health, Qlife aims to provide lab-quality ... |
| 05.03.2025 | Qlife carries out a directed issue to guarantors in connection with the completed rights issue and a directed issue of warrants to JEQ Capital AB | Qlife carries out a directed issue to guarantors in connection with the completed rights issue and a directed issue of warrants to JEQ Capital AB
Wed, Mar 05, 2025 11:31 CET Report this content
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, ... |
| 04.03.2025 | Qlife reaffirms its strategy and plans to expand the Board with three new members | Qlife reaffirms its strategy and plans to expand the Board with three new members
Tue, Mar 04, 2025 10:45 CET Report this content
Following a successful rights issue, Qlife has convened an extraordinary general meeting to expand its Board o... |
| 04.03.2025 | Notice of Extraordinary General Meeting 2025 in Qlife Holding AB | Notice of Extraordinary General Meeting 2025 in Qlife Holding AB
Tue, Mar 04, 2025 10:40 CET Report this content
Qlife Holding AB, reg.no. 559224-8040 (the ”Company”), will hold an Extraordinary General Meeting on 21 March 2025 at. 10.00 at... |
| 26.02.2025 | Qlife announces outcome in rights issue | Qlife announces outcome in rights issue
Wed, Feb 26, 2025 19:27 CET Report this content
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERICA, AUSTRALIA, BELARUS, CANADA, HONG KONG, J... |
| 21.02.2025 | Navigating the Financial Waters: Qlife and Spermosens in Focus | In the ever-shifting landscape of biotechnology and medical technology, two companies stand out: Qlife Holding AB and Spermosens AB. Both are Swedish firms, each charting its own course through the turbulent seas of investment and innovatio... |
| 21.02.2025 | Qlife has successfully verified the biomarkers related to the previously announced LOI | Qlife has successfully verified the biomarkers related to the previously announced LOI
Fri, Feb 21, 2025 09:00 CET Report this content
Qlife is pleased to announce that, in collaboration with Hipro Biotechnology, the company has successfull... |
| 21.02.2025 | The subscription period in Qlife’s rights issue ends on Tuesday, 25 February 2025 | The subscription period in Qlife’s rights issue ends on Tuesday, 25 February 2025
Fri, Feb 21, 2025 10:00 CET Report this content
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERICA... |
| 18.02.2025 | Qlife's Bold Leap into Women's Health: A New Era of Home Diagnostics | In a world where health is often a puzzle, Qlife is handing out the pieces. The Swedish company has unveiled a groundbreaking expansion of its Egoo.Health platform, introducing innovative biomarkers and AI-driven insights tailored for women... |
| 17.02.2025 | Qlife announces the launch of Egoo.AI and the start of sales for the Women’s Health platform | Qlife announces the launch of Egoo.AI and the start of sales for the Women’s Health platform
Mon, Feb 17, 2025 09:00 CET Report this content
Qlife is proud to announce a major expansion of Egoo.Health with the launch of Egoo.AI, an advanced... |
| 14.02.2025 | Qlife and Nordnet: Navigating Financial Waters Amidst Technical Storms | In the world of finance, clarity is gold. Recently, two significant events unfolded in the Nordic market, shedding light on the resilience and challenges faced by companies in this digital age. Qlife Holding AB and Nordnet both found themse... |
| 14.02.2025 | Qlife launches Thyroid Disease and Vitamin D biomarkers, now available for immediate sales | Qlife launches Thyroid Disease and Vitamin D biomarkers, now available for immediate sales
Fri, Feb 14, 2025 09:00 CET Report this content
Qlife is proud to announce the expansion of the Egoo.Health biomarker menu within the General Health ... |
| 12.02.2025 | Members of the Board of Directors and management intend to subscribe in the ongoing rights issue | Members of the Board of Directors and management intend to subscribe in the ongoing rights issue
Wed, Feb 12, 2025 08:00 CET Report this content
Qlife Holding AB (publ) (“Qlife” or the “Company”) announces that members of the Company's Boar... |
| 11.02.2025 | Qlife's Rights Issue: A Strategic Move for Growth | In the fast-paced world of biotechnology, companies often find themselves at a crossroads. For Qlife Holding AB, that moment has arrived. The Swedish company, known for its innovative medical technology platform, Egoo.Health, is embarking o... |
| 11.02.2025 | The subscription period in Qlife’s rights issue begins today | The subscription period in Qlife’s rights issue begins today
Tue, Feb 11, 2025 08:00 CET Report this content
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERICA, AUSTRALIA, BELARUS,... |
| 10.02.2025 | Qlife publishes information memorandum due to upcoming rights issue | Qlife publishes information memorandum due to upcoming rights issue
Mon, Feb 10, 2025 14:00 CET Report this content
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERICA, AUSTRALIA, B... |
| 30.01.2025 | Qlife's Strategic Moves: A Financial Lifeline and Promising Partnerships | In the fast-paced world of biotechnology, companies often find themselves at a crossroads. For Qlife Holding AB, that moment has arrived. The company is navigating through a significant financial maneuver while simultaneously forging strate... |
| 29.01.2025 | Qlife carries out a rights issue of approximately SEK 11.8 million and enters into an agreement for a credit facility of SEK 5.6 million | Qlife carries out a rights issue of approximately SEK 11.8 million and enters into an agreement for a credit facility of SEK 5.6 million
Wed, Jan 29, 2025 07:59 CET Report this content
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY ... |
| 28.01.2025 | Qlife has signed a letter of intent with a top-20 global Pharma company to explore a potential commercial collaboration | Qlife has signed a letter of intent with a top-20 global Pharma company to explore a potential commercial collaboration
Tue, Jan 28, 2025 09:00 CET Report this content
Qlife has been in discussions with a top-20 global Pharma company to exp... |
| 18.01.2025 | Qlife's Leap into Home Diagnostics: A New Era of Health Monitoring | In the fast-paced world of healthcare, innovation is the lifeblood that keeps the industry thriving. Qlife, a rising star in the home diagnostics arena, is making waves with its Egoo Health platform. This platform is not just a product; it’... |
| 16.01.2025 | Qlife announces introduction of a CE-approved joint developed Egoo Health platform for immediate sales | Qlife announces introduction of a CE-approved joint developed Egoo Health platform for immediate sales
Thu, Jan 16, 2025 09:00 CET Report this content
The company is pleased to announce that Qlife, in collaboration with its strategic partne... |
| 14.01.2025 | Qlife provides sales and regulatory updates | Qlife provides sales and regulatory updates
Tue, Jan 14, 2025 09:00 CET Report this content
The company has shifted its focus from research and development to becoming a sales-driven organization, emphasizing the distribution of its high-qu... |
| 07.01.2025 | Qlife provides update on operational progress in China | Qlife provides update on operational progress in China
Tue, Jan 07, 2025 09:00 CET Report this content
Since the summer, Qlife has been working diligently in close collaboration with its partner, Hipro Biotechnology, in China. The company i... |
| 08.11.2024 | Bulletin from the extraordinary general meeting, and the second control meeting, in Qlife Holding AB on 8 November 2024 | Bulletin from the extraordinary general meeting, and the second control meeting, in Qlife Holding AB on 8 November 2024
Fri, Nov 08, 2024 10:39 CET Report this content
Today, on 8 November 2024, an extraordinary general meeting, and the sec... |
| 09.10.2024 | Railway Metrics and Dynamics Sweden AB: A Strategic Move for Growth | In the fast-paced world of finance, companies often find themselves at a crossroads. For Railway Metrics and Dynamics Sweden AB (publ), that moment has arrived. On October 8, 2024, the board announced a partially guaranteed rights issue aim... |
| 07.10.2024 | Qlife withdraws proposal to change company name | Qlife withdraws proposal to change company name
Mon, Oct 07, 2024 19:59 CET Report this content
Qlife Holding AB (publ) (“Qlife” or the “Company”) has decided to withdraw its proposal to change the Company’s name as the intended name, Egoo ... |
| 07.10.2024 | Kallelse till extra bolagsstämma i Qlife Holding AB tillika andra kontrollstämma | Kallelse till extra bolagsstämma i Qlife Holding AB tillika andra kontrollstämma
Mon, Oct 07, 2024 20:06 CET Report this content
Aktieägarna i Qlife Holding AB, org.nr 559224-8040 (”Bolaget”), kallas till extra bolagsstämma, tillika andra k... |
| 02.10.2024 | Qlife Launches At-Home PHE Test: A Game Changer for Rare Disease Management | In a world where convenience often trumps traditional methods, Qlife is stepping into the spotlight with its new at-home Phenylalanine (PHE) test. This innovative product targets individuals with Phenylketonuria (PKU), a rare genetic disord... |
| 02.10.2024 | Qlife starts sales of its PHE rare disease test, addressing an unmet need in the at-home testing market worth SEK 2.5 billion | Qlife starts sales of its PHE rare disease test, addressing an unmet need in the at-home testing market worth SEK 2.5 billion
Wed, Oct 02, 2024 08:55 CET Report this content
Resent due to technical problems news distributor.
Since its incep... |
| 01.10.2024 | Qlife starts sales of its PHE rare disease test, addressing an unmet need in the at-home testing market worth SEK 2.5 billion | Qlife starts sales of its PHE rare disease test, addressing an unmet need in the at-home testing market worth SEK 2.5 billion
Tue, Oct 01, 2024 09:00 CET Report this content
Since its inception, Qlife has been developing the Phenylalanine (... |
| 10.09.2024 | Qlife is pleased to announce that Peter Warthoe will return to the management group as Chief Scientific Officer | Qlife is pleased to announce that Peter Warthoe will return to the management group as Chief Scientific Officer
Tue, Sep 10, 2024 09:00 CET Report this content
Peter Warthoe, one of the three founders of Qlife, is back in his management rol... |
| 06.09.2024 | Qlife's Strategic Shift: A New Era for Egoo Health in China | In the fast-paced world of medical technology, Qlife Holding AB is making waves. The company has recently established a production line for its Egoo consumables in China. This move is not just a logistical triumph; it’s a strategic pivot ai... |
| 06.09.2024 | Qlife Holding AB (publ) is pleased to announce that it publishes a second balance sheet for liquidation purposes showing that the Company's total equity exceeds the registered share capital | Qlife Holding AB (publ) is pleased to announce that it publishes a second balance sheet for liquidation purposes showing that the Company's total equity exceeds the registered share capital
Fri, Sep 06, 2024 13:03 CET Report this content
Ql... |
| 04.09.2024 | Production of Egoo consumables now established in China to support on-going clinical trials and future sales | Production of Egoo consumables now established in China to support on-going clinical trials and future sales
Wed, Sep 04, 2024 09:00 CET Report this content
Qlife Holding AB (publ) (“Qlife” or the “Company”) recently announced a restructuri... |
| 19.07.2024 | Qlife Holding AB’s subsidiary Qlife ApS terminates corporate restructuring and files for bankruptcy. Qlife Holding AB investigates a capital raise and to submit an offer to repurchase the assets. | Qlife Holding AB’s subsidiary Qlife ApS terminates corporate restructuring and files for bankruptcy. Qlife Holding AB investigates a capital raise and to submit an offer to repurchase the assets.
Fri, Jul 19, 2024 09:10 CET Report this cont... |
| 26.06.2024 | Kommuniké från årsstämma 2024 i Qlife Holding AB | Kommuniké från årsstämma 2024 i Qlife Holding AB
Wed, Jun 26, 2024 11:34 CET Report this content
Qlife Holding AB höll den 26 juni 2024 årsstämma varvid i huvudsak följande beslut fattades.
Fastställande av räkenskaper samt resultatdisposit... |
| 10.06.2024 | Qlife Holding AB publishes information by reason of ongoing negotiations with Atlas Special Opportunities, LLC, regarding a financing solution | Qlife Holding AB publishes information by reason of ongoing negotiations with Atlas Special Opportunities, LLC, regarding a financing solution
Mon, Jun 10, 2024 15:08 CET Report this content
Qlife Holding AB (“Qlife” or the “Company”) and A... |
| 26.05.2024 | Kallelse till årsstämma 2024 i Qlife Holding AB | Kallelse till årsstämma 2024 i Qlife Holding AB
Sun, May 26, 2024 22:00 CET Report this content
Aktieägarna i Qlife Holding AB, org.nr 559224-8040, kallas till årsstämma den 26 juni 2024 kl. 10.00 i Hetchs lokaler på Redaregatan 48 i Helsin... |
| 08.05.2024 | Qlife Holding AB enters into an addendum with the holders of the company’s convertible debentures and all outstanding convertible debentures are converted into shares | Qlife Holding AB enters into an addendum with the holders of the company’s convertible debentures and all outstanding convertible debentures are converted into shares
Wed, May 08, 2024 07:46 CET Report this content
Qlife Holding AB (“Qlife”... |
| 23.04.2024 | Bulletin from the extraordinary general meeting, and the first meeting for liquidation purposes, in Qlife Holding AB on 23 April 2024 | Bulletin from the extraordinary general meeting, and the first meeting for liquidation purposes, in Qlife Holding AB on 23 April 2024
Tue, Apr 23, 2024 09:55 CET Report this content
Today, on 23 April 2024, an extraordinary general meeting,... |
| 27.03.2024 | UPDATE: Qlife is emphasizing its strategy to finalize regulatory and Go-To-Market in China, register in Asian countries through partners, and then file for approval in the UK and EU | UPDATE: Qlife is emphasizing its strategy to finalize regulatory and Go-To-Market in China, register in Asian countries through partners, and then file for approval in the UK and EU
Wed, Mar 27, 2024 11:38 CET Report this content
It has bee... |
| 25.03.2024 | Qlife signs letter of intent with South Korean company Precision Biosensor as part of B2B strategy to enter major markets with Egoo Health, through hospital@home partnerships | Qlife signs letter of intent with South Korean company Precision Biosensor as part of B2B strategy to enter major markets with Egoo Health, through hospital@home partnerships
Mon, Mar 25, 2024 08:00 CET Report this content
Qlife is pleased ... |
| 21.03.2024 | UPDATE: Qlife is emphasizing that the call today for an extraordinary general meeting (EGM) is a necessity according to Swedish law, but that the company otherwise is following its plans. | UPDATE: Qlife is emphasizing that the call today for an extraordinary general meeting (EGM) is a necessity according to Swedish law, but that the company otherwise is following its plans.
Thu, Mar 21, 2024 17:33 CET Report this content
Qlif... |
| 21.03.2024 | Qlife has prepared a balance sheet for liquidation purposes and the board of directors will convene an extraordinary general meeting (for liquidation purposes) | Qlife has prepared a balance sheet for liquidation purposes and the board of directors will convene an extraordinary general meeting (for liquidation purposes)
Thu, Mar 21, 2024 15:48 CET Report this content
The board of directors of Qlife ... |
| 21.03.2024 | Notice of extraordinary general meeting, and the first meeting for liquidation purposes, in Qlife Holding AB | Notice of extraordinary general meeting, and the first meeting for liquidation purposes, in Qlife Holding AB
Thu, Mar 21, 2024 18:25 CET Report this content
The English text is an unofficial translation. In case of any discrepancies between... |
| 29.02.2024 | Qlife publishes outcome in rights issue | Qlife publishes outcome in rights issue
Thu, Feb 29, 2024 20:14 CET Report this content
On 12 December 2023, Qlife Holding AB (“Qlife” or the “Company”) announced a rights issue of units of approximately SEK 49.5 million (the “Rights Issue”... |
| 23.02.2024 | The subscription period in Qlife’s rights issue ends on Monday, February 26, 2024 | The subscription period in Qlife’s rights issue ends on Monday, February 26, 2024
Fri, Feb 23, 2024 17:43 CET Report this content
Monday, February 26, 2024, is the last day of the subscription period in Qlife Holding AB’s (“Qlife” or the “C... |
| 23.02.2024 | Qlife’s core patent granted in Europe | Qlife’s core patent granted in Europe
Fri, Feb 23, 2024 13:48 CET Report this content
Qlife announces that its core patent for the Egoo system has been granted in the EU and other countries in the European market, as well as in the United K... |
| 16.02.2024 | Qlife reports first milestone achieved and on track with Chinese collaboration | Qlife reports first milestone achieved and on track with Chinese collaboration
Fri, Feb 16, 2024 09:00 CET Report this content
UPDATE: Qlife has previously reported the potential of its Chinese collaboration and is now updating accordingly:... |
| 12.02.2024 | The subscription period in Qlife’s rights issue begins today | The subscription period in Qlife’s rights issue begins today
Mon, Feb 12, 2024 17:40 CET Report this content
Today, February 12, 2024, is the first day of the subscription period in Qlife Holding AB’s (“Qlife” or the “Company”) issue of a m... |
| 12.12.2023 | Notice of extraordinary general meeting in Qlife Holding AB | Notice of extraordinary general meeting in Qlife Holding AB
Tue, Dec 12, 2023 23:15 CET Report this content
The shareholders of Qlife Holding AB, Reg. No. 559224-8040, are hereby invited to attend the extraordinary general meeting to be hel... |
| 01.12.2023 | Management changes in Qlife Holding AB | Management changes in Qlife Holding AB
Fri, Dec 01, 2023 08:00 CET Report this content
Qlife Holding AB is pleased to announce the appointment of Peter Thorsen as the new Chief Financial Officer (CFO) of the company, effective January 1st, ... |
| 06.10.2023 | Which Medical Startups Shape Hovedstaden’s Healthcare Landscape in 2023? | The health industry in Hovedstaden, Denmark is teeming with creative and innovative startups aiming to make their mark in medical technology, therapeutics, and diagnostics. These startups are not only revolutionizing their local health indu... |
| 19.08.2023 | Innovative Medical Startups in Denmark: Pioneering the Future of Healthcare | Step into Denmark’s vibrant medical startup landscape, where innovation intersects with healthcare. Join us as we explore 15 groundbreaking startups that are reshaping the medical industry, advancing treatments, and enhancing the quality of... |
| 25.07.2023 | Hovedstaden’s Hotshots: Exploring the 15 Most Innovative Information Technology Startups in Denmark | Denmark’s Hovedstaden region, brimming with innovative ideas and pioneering startups, is on the precipice of an information technology revolution. Let’s get to know the 15 most captivating IT startups that are disrupting traditional landsca... |
| 09.07.2023 | Redefining Healthcare: 15 Danish Startups Reshaping the Medical Landscape | Table of Contents show
1 1. Scandinavian Biolabs: Restoring Confidence, One Strand at a Time
2 2. Egoo.Health: Revolutionizing Biomarker Testing
3 3. CysBio: Bio-solutions from University to Market
4 4. Ciana Therapeutics: Shining a Lig... |
| 27.06.2023 | Launch of Egoo Innovate at AACC - to promote faster and targeted implementation of critical biomarker assays into at-home testing | Launch of Egoo Innovate at AACC - to promote faster and targeted implementation of critical biomarker assays into at-home testing
Tue, Jun 27, 2023 10:00 CET Report this content
Join us at AACC (American Association for Clinical Chemistry) ... |
| 13.04.2023 | Qlife fully secures ongoing rights issue with top guarantee commitments | Qlife fully secures ongoing rights issue with top guarantee commitments
Thu, Apr 13, 2023 09:50 CET Report this content
Qlife Holding AB (“Qlife” or the “Company”) has secured a top guarantee syndicate, in addition to the previously announc... |
| 24.03.2023 | Bulletin from the extraordinary general meeting in Qlife Holding AB on 24 March 2023 | Bulletin from the extraordinary general meeting in Qlife Holding AB on 24 March 2023
Fri, Mar 24, 2023 14:45 CET Report this content
Today, on 24 March 2023, an extraordinary general meeting was held in Qlife Holding AB. A summary of the ad... |
| 13.03.2023 | Qlife announces that Aidian has initiated arbitration proceedings against Qlife | Qlife announces that Aidian has initiated arbitration proceedings against Qlife
Mon, Mar 13, 2023 22:16 CET Report this content
Qlife Holding interim report for Q4 2022 included aged accounts payable owed to the Finish company Adidan Oy of ... |
| 16.02.2023 | Notice of extraordinary general meeting in Qlife Holding AB | Notice of extraordinary general meeting in Qlife Holding AB
Thu, Feb 16, 2023 23:39 CET Report this content
The English text is an unofficial translation. In case of any discrepancies between the Swedish text and the English translation, th... |
| 18.11.2022 | Qlife puts development of two-in-one test on hold | Qlife puts development of two-in-one test on hold
Fri, Nov 18, 2022 10:51 CET Report this content
Today, Qlife announces that a delay in finalizing the development of the two-in-one test for influenza and SARS-CoV-2 virus assay, and associa... |
| 20.10.2022 | Qlife announces outcome in rights issue | Qlife announces outcome in rights issue
Thu, Oct 20, 2022 19:00 CET Report this content
On 24 August 2022, Qlife Holding AB (“Qlife” or the “Company”) announced a rights issue of units of approximately SEK 76 million (the “Rights Issue”). T... |
| 20.09.2022 | Qlife to participate in investor presentations in September 2022 | Qlife to participate in investor presentations in September 2022
Tue, Sep 20, 2022 09:00 CET Report this content
Qlife will participate in two investor days in September where the company's CEO Thomas Warthoe presents the company and gives ... |
| 24.08.2022 | Notice of extraordinary general meeting in Qlife Holding AB | Notice of extraordinary general meeting in Qlife Holding AB
Wed, Aug 24, 2022 08:05 CET Report this content
The shareholders of Qlife Holding AB, Reg. No. 559224-8040, are hereby invited to attend the extraordinary general meeting to be hel... |
| 24.08.2022 | Qlife Holding AB, Interim report Q2 2022 | Qlife Holding AB, Interim report Q2 2022
Wed, Aug 24, 2022 08:15 CET Report this content
INCREASED FOCUS ON R&D ROADMAP
FINANCIAL SUMMARY – SECOND QUARTER 2022
Revenue in the period amounted to kSEK 4,025 (10.482). Revenue includes sale... |
| 24.08.2022 | Qlife carries out a rights issue of units of approximately SEK 76 million and brings forward the publication of the interim report for the first half of 2022 | Qlife carries out a rights issue of units of approximately SEK 76 million and brings forward the publication of the interim report for the first half of 2022
Wed, Aug 24, 2022 08:00 CET Report this content
The board of directors of Qlife Ho... |
| 18.08.2022 | Qlife updates vision and websites – Reinforced emphasis on making Egoo Health available for home use | Qlife updates vision and websites – Reinforced emphasis on making Egoo Health available for home use
Thu, Aug 18, 2022 08:30 CET Report this content
Qlife today presents an updated vision and new websites for corporate and IR communication ... |
